News

Cerillion Earns ODA Approval, Enhancing Telecom Solutions

Cerillion Earns ODA Approval, Enhancing Telecom Solutions

Cerillion Achieves ODA Approval Marking a Significant Milestone

Cerillion, a prominent provider of BSS/OSS-as-a-Service solutions, has recently announced a remarkable accomplishment. The company has achieved the "Ready for ODA" status with TM Forum for two of its flagship products from its pre-integrated BSS/OSS suite. This growth follows their Platinum certification in TM Forum's Open API programme, which highlights Cerillion's robust APIs validated through multiple live customer environments exhibiting tangible performance and interoperability.

Understanding TM Forum's Open Digital Architecture

TM Forum's Open Digital Architecture (ODA) serves as a crucial framework for Communications Service Providers (CSPs) and suppliers aiming to enhance business agility. By creating clearer, more manageable IT solutions, ODA enables easier implementation and upgrades, thereby improving both customer experience and operational effectiveness. Attaining the "Ready for ODA" status signifies that a company’s products not only comply with ODA's principles but also meet rigorous evaluation standards for quality and implementation.

Implications of the Achievement for Cerillion

"Attaining the 'Ready for ODA' status is a significant endorsement of our focus on technology that enables CSPs to accelerate their innovation processes," stated Louis Hall, Cerillion's CEO. This recognition underscores Cerillion’s dedication to promoting collaboration and streamlined operations, which are essential for its customers on a global scale.

Key Products Recognized for ODA Compliance

The two flagship products that received the "Ready for ODA" acknowledgment are integral to Cerillion’s extensive digital transformation vision. The first, CRM Plus, is a sophisticated omni-channel CRM platform. It empowers CSPs to craft personalized customer experiences while effectively managing the lifecycle for both consumer and business sectors.

Innovative Solutions to Transform Customer Experiences

The second accoladed product, the Enterprise Product Catalogue, utilizes advanced AI technology, including natural language processing and image recognition. This innovation simplifies product lifecycle management, significantly shortens the time needed to introduce new services, and facilitates the easy assembly of complex offerings, fostering enhanced market responsiveness.

Collaborative Efforts Highlighted in the Achievement

TM Forum representatives also expressed their appreciation for Cerillion's accomplishments. Andy Tiller, EVP Products & Services at TM Forum, acknowledged the importance of collaboration within the industry: "Cerillion's achievement is a direct result of their commitment to implementing ODA standards and contributing to its development through TM Forum's collaborative programmes. Collaborating effectively is vital to ensuring the telecom IT industry thrives, and Cerillion's proactive role benefits the entire ecosystem of telecom solutions.

About Cerillion and Its Offerings

Founded in 1999, Cerillion has established itself as a key player in providing billing, charging, and customer management systems across various sectors, including telecommunications, finance, and utilities. With approximately 80 customer installations in nearly 45 countries, Cerillion's diverse clientele includes industry leaders like Liberty Global and Virgin Media. Their commitment to excellence and innovation continues to propel their success in delivering tailored solutions to meet evolving market demands.

Frequently Asked Questions

1. What is the significance of Cerillion achieving ODA status?

Achieving ODA status indicates that Cerillion's products meet TM Forum's rigorous evaluation and standards, enhancing their credibility and appeal in the telecom market.

2. What are the two key products recognized for ODA compliance?

The two products are CRM Plus and Enterprise Product Catalogue, both integral to Cerillion's strategy in digital transformation.

3. How does TM Forum's Open Digital Architecture benefit CSPs?

TM Forum's ODA provides a framework that enhances business agility, simplifies IT solutions, and improves customer service and operational efficiency.

4. Who is Cerillion's target market?

Cerillion serves a variety of industries but primarily focuses on telecommunications, finance, and utilities, providing tailored solutions for each sector.

5. When was Cerillion founded?

Cerillion was founded in 1999 and has grown substantially since then, establishing itself as a leader in the delivery of innovative BSS/OSS solutions.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 7

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
HTX's Strategic Moves in Pakistan: A Crypto Frontier

Updated Category News Views 5

Paving the Way: HTX's Journey in Pakistan Rolling into the Pakistan cryptocurrency scene isn't just a 'walk in the park' for HTX—it's more like traversing a new frontier with an open map. This isn’t some hit-and-run operation; HTX is strategizing for a long haul in one of the liveliest digital market arenas in South Asia. Gathering steam with community AMAs and an X...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 6

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 6

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
Davos Healthcare Aims to Revolutionize Hospital Ratings

Updated Category News Views 3

Throw away those dusty, old reputation surveys—Davos Healthcare just turned the spotlight onto cold, hard data with its new global hospital evaluation platform. Why Davos Healthcare’s Initiative Matters At the C3 US NYC Davos of Healthcare™ Summit, an event that’s rooted itself alongside the United Nations General Assembly, Davos Healthcare unveiled a...

Continue Reading
Sean Trahan Joins Citrin Cooperman: New Tax Lead

Updated Category News Views 5

Citrin Cooperman's Strategic Tax Move If there's one phrase that can spark a debate at a financial water cooler, it's 'transfer pricing.' Today, Citrin Cooperman is throwing its hat further into that ring with the appointment of Sean Trahan as head of their new Transfer Pricing and Value Chain Optimization Practice. This isn't just another reshuffling of office...

Continue Reading
Leapora's Taskeen: Redefining Task Accountability

Updated Category News Views 2

AI's Impact on Workplace Task Management In today’s whirlwind of AI-generated output, transparency is not just a luxury; it’s a necessity. AI systems churn out work that can appear polished but often lacks substance. This doesn't just create headaches; it triggers a ticking bomb in the regulatory department. According to a 2025 survey from Stanford and BetterUp Labs,...

Continue Reading
The Chemical Industry and EPA: A Broken System?

Updated Category News Views 3

Decades of an Unchecked Revolving Door The Environmental Protection Agency (EPA) and chemical manufacturers—a dance that’s been going on for what seems like forever. But not in the way you might hope. We're talking about a revolving door where execs and lobbyists waltz into regulatory chairs while regulators slide into cushy industry gigs. Wisner Baum LLP, a stickler...

Continue Reading
K-Beauty Takes Front Stage at Target Beauty Studio

Updated Category News Views 4

Making Waves in the U.S. with K-Beauty SUNGBOON EDITOR and Milk Touch just rolled into Target Beauty Studio, making a splash in the world of K-beauty. From ingredients that boast serious benefits to playful cosmetics that let you express yourself, these brands are shaking up American beauty routines in a big way. Ingredient-Focused Skincare for Every American Face...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 7

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading

Top 5 Most Recently Viewed Articles

Shell plc: Recent Share Transactions by Management Team

Updated Category News Views 110

Shell plc made some serious moves back in September 2024 that had traders scratching their heads and looking for the fine print. They let loose a slew of notifications about share transactions by its Persons Discharging Managerial Responsibilities (PDMRs), making waves in the market. This isn’t just corporate fluff; it’s a playbook for transparency and compliance that...

Continue Reading
zSpace Faces Class Action Over IPO Missteps: Key Probe

Updated Category News Views 5

Unpacking the Explosive Allegations Against zSpace You think you're safe diving into augmented reality stocks, and then a bombshell lands. zSpace, Inc. (NASDAQ:ZSPC), a supposed leader in AR and VR educational tech, finds itself in the swirling midst of a class action lawsuit. Investors are rattled, and they're not just buzzing because their portfolios took a hit. There's...

Continue Reading
Transforming Spending: WisdomTree's Innovative Feature Launch

Updated Category News Views 164

WisdomTree Introduces Earn-Until-You-Spend Feature WisdomTree, Inc. (NYSE: WT), a leader in financial innovation, has recently announced a significant enhancement to its user experience with the introduction of a new feature allowing customers to utilize their accrued interest from the WisdomTree Government Money Market Digital Fund (WTGXX) as a funding source for the...

Continue Reading
AVITA Medical Set to Share Third Quarter 2025 Results Soon

Updated Category News Views 163

AVITA Medical to Report Financial Results AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a prominent company in therapeutic acute wound care, has made headlines with its upcoming financial disclosure. The firm is set to unveil its third-quarter financial results for 2025 after the U.S. markets close on the scheduled date. This announcement is anticipated by investors who...

Continue Reading
Hyperscale Data Celebrates Sustainable Growth with Dividends

Updated Category News Views 45

Hyperscale Data's Commendable Dividend Achievement LAS VEGAS — Hyperscale Data, Inc. (NYSE: GPUS) proudly announced it has consistently paid cash dividends for twenty-eight consecutive months on its Series D Preferred Stock. This dividend, amounting to 13.00% annually, equates to approximately $0.2708 for each share, paid monthly. This remarkable track record...

Continue Reading